MMP11 and neoplasm: Also, in the clinicopathological and survival analyses, upregulated MMP11 was significantly associated with a higher tumor stage (p = 0.003), a shorter OS (HR = 1.23, p = 3.71 × 10−2), a shorter PFS time (HR = 1.33, p = 2.15 × 10−3), and a shorter RFS time (HR = 1.24, p = 1.71 × 10−3).